- 產(chǎn)品描述
藥物濫用違禁品(肝炎)檢測(cè)試劑盒
廣州健侖生物科技有限公司
廣州健侖生物長(zhǎng)期供應(yīng)各種違禁品檢測(cè)試紙、違禁品檢測(cè)卡、違禁品檢測(cè)試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測(cè)試劑盒、巴比妥檢測(cè)試劑盒等。
如需訂購(gòu)或者了解請(qǐng)以下或
mob: 楊 :
主營(yíng)品牌:美國(guó)NovaBios、美國(guó)Cortez、國(guó)產(chǎn)創(chuàng)侖等等。
主要用途:篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。
檢測(cè)范圍:嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。
產(chǎn)品特點(diǎn):可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合,從二聯(lián)到十五聯(lián)都可以訂制。
以下是部分產(chǎn)品違禁品檢測(cè)
藥物濫用違禁品(肝炎)檢測(cè)試劑盒
【儲(chǔ)存條件及有效期】
儲(chǔ)存條件:原包裝應(yīng)儲(chǔ)存于4~30℃避光干燥處,切忌冷凍。
有效期:24個(gè)月。
規(guī)格:40T/盒
試劑盒應(yīng)在鋁箔袋拆封后1小時(shí)內(nèi)盡快使用;建議在周圍溫度高于30℃或高濕度條件下,盡可能做到即開(kāi)即用。
本品采用競(jìng)爭(zhēng)抑制法和膠體金免疫層析技術(shù),用于定性檢測(cè)人體尿液中尼古丁,適用于尼古丁藥物濫用的初步篩查。
The autumn of November 3, 2017 is the best time to hold group events and strengthen the cohesion of the company. Guangzhou Jianlun Biotechnology Co., Ltd. upholds the concepts and attitudes of solidarity, fraternity, mutual aid, dedication, collaboration, and innovation. To improve the physical fitness of employees and strengthen corporate culture, it actively participates in the Games organized by this Science Park.
At 2 o'clock in the afternoon, in the sun, in the song, on the field, the first fun games of Panyu Innovation and Technology Park kicked off! With the high voice of the host, the crowds on the court lined up in neat rows. The team leader stood in the front of the team holding up the signs of each representative team. The participating athletes were eagerly arranged in the ranks and waiting for the start of the sports meeting. Then, the leader of the Science Park and the leader of the Guangzhou Mountaineering Association made a speech and wished the Games a success!
After the opening ceremony, under the leadership of the host, the athletes completed the warm-up exercise. The upcoming game is a rousing game. The company's first competition program is to test the coordination of the body and teamwork thunderbolt. As the whistle sounded, six colleagues carefully waved the balloons on the drums with a concerted pace and rhythm. The two colleagues were waiting for their help and were ready to pick up the flunging balloons. With nervousness and excitement, every colleague is working hard to complete the game. With the sound of the referee's ending, colleagues were relaxed, but due to lack of exercise, our performance on this project was not satisfactory. The company’s leader, Zhan Zhan, encouraged everyone at this time to cheer up morale and achieved better results in the next game.
At three o'clock in the afternoon, the colleagues of Jianlun Biology were engaged in a penalties game. Accompanied by cheers, I saw my colleagues kick one exciting goal after another and the score went up. In the end, Jianlun Bios achieved good results in the top five on this project. During the intermission, Zhan summoned everyone to a brief summary and encouraged everyone to continue their efforts to achieve better performance. Sure enough, in the following tortoise-bitch races and super-shooting sessions, colleagues performed better and better, demonstrating the positive appearance of Jianlun Biocorp. and the corporate culture of solidarity and cooperation.
At five o'clock in the afternoon, as the last athlete crossed the finish line, the game also came to a close. In the next award ceremony, the winning teams and athletes received commendation and prizes. The sports event was over, but the success and spirit gained through the games will continue to circulate, and it will become a shining landscape on the path of Guangzhou Jianlun Biosciences!
努力,我們一直在路上,明天會(huì)更好!
我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒:登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲(chóng)病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測(cè)、食品安全檢測(cè)等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。
更多產(chǎn)品說(shuō)明可通過(guò)下方的進(jìn)行了解
添加掃一掃二維碼:
【公司名稱】 廣州健侖生物科技有限公司
【 市場(chǎng)部 】 楊永漢
【】
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號(hào)二期2幢101-103室
(metlproteinse,MP)類,如膠原酶IV、基質(zhì)降解酶、透明質(zhì)酸 酶.惡性腫瘤的發(fā)生、發(fā)展、侵襲和轉(zhuǎn)移常常伴有細(xì)胞外基質(zhì) (extrcellulr mtrix,ECM)及其細(xì)胞表面受體表達(dá)的變化。正 常肝細(xì)胞沒(méi)有基膜,也不表達(dá)層粘連蛋白(lminin,LN)的特異性 整合素族受體αβ;而在肝細(xì)胞癌(humn heptocellulr crcinom,HCC)組織中,LN和αβ不僅表達(dá)水平升高,呈明顯 的共分布,而且其高水平表達(dá)與肝癌患者的預(yù)后呈負(fù)相關(guān),提示 HCC細(xì)胞可能通過(guò)αβ受體接受來(lái)自LN的信號(hào),從而對(duì)肝癌細(xì)胞 的侵襲行為起著不可忽視的作用。肝癌的發(fā)病過(guò)程中往往早期就出 現(xiàn)門靜脈侵襲、肝內(nèi)轉(zhuǎn)移以及肝外肺臟和骨組織的轉(zhuǎn)移,肝癌的侵 襲、轉(zhuǎn)移和術(shù)后復(fù)發(fā)是影響患者預(yù)后的主要因素?;|(zhì)金屬蛋白酶 (mtrix met-lloproteinses,MMPs)對(duì)ECM的降解是腫瘤細(xì)胞 侵襲和轉(zhuǎn)移的關(guān)鍵環(huán)節(jié)之一,多種惡性腫瘤都伴有MMPs分泌水平 和活性的增高。細(xì)胞外基質(zhì)(ECM)是組成間質(zhì)和上皮血管中基質(zhì)的不溶性結(jié)構(gòu)成分 ,主要有膠原蛋白、彈性蛋白、蛋白多糖和糖蛋白等。
(metylproteinse, MP) class, such as collagenase IV, matrix degrading enzyme, hyaluronidase. The occurrence, development, invasion, and metastasis of malignant tumors are often accompanied by expression of extracellular matrix (ECM) and its cell surface receptors. The change. Normal hepatocytes do not have a basement membrane and do not express laminin (LN)-specific integrin receptor αβ; whereas in hepatocellular carcinoma (HCC), LN and αβ not only express higher levels of expression. It is highly co-distribution, and its high-level expression is negatively correlated with the prognosis of patients with liver cancer, suggesting that HCC cells may receive signals from LN through the αβ receptor, and thus play an important role in the invasion behavior of hepatoma cells. In the process of liver cancer, portal vein invasion, intrahepatic metastasis, and extrahepatic lung and bone metastasis often occur early. The invasion, metastasis, and postoperative recurrence of liver cancer are the main factors affecting the prognosis of patients. The degradation of ECM by matrix metalloproteinases (MMPs) is one of the key steps in the invasion and metastasis of tumor cells. Many malignant tumors are accompanied by an increase in the secretion level and activity of MMPs. The extracellular matrix (ECM) is the insoluble structural component that constitutes the matrix in the interstitial and epithelial blood vessels, and is mainly composed of collagen, elastin, proteoglycans and glycoproteins.